Rimm D - Search Results

1

Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.

Dieci MV, Radosevic-Robin N, Fineberg S, van den Eynden G, Ternes N, Penault-Llorca F, Pruneri G, D'Alfonso TM, Demaria S, Castaneda C, Sanchez J, Badve S, Michiels S, Bossuyt V, Rojo F, Singh B, Nielsen T, Viale G, Kim SR, Hewitt S, Wienert S, Loibl S, Rimm D, Symmans F, Denkert C, Adams S, Loi S, Salgado R; International Immuno-Oncology Biomarker Working Group on Breast Cancer. Dieci MV, et al. Among authors: rimm d, d alfonso tm. Semin Cancer Biol. 2018 Oct;52(Pt 2):16-25. doi: 10.1016/j.semcancer.2017.10.003. Epub 2017 Oct 9. Semin Cancer Biol. 2018. PMID: 29024776 Free article. Review.

2

Expression of c-met is a strong independent prognostic factor in breast carcinoma.

Ghoussoub RA, Dillon DA, D'Aquila T, Rimm EB, Fearon ER, Rimm DL. Ghoussoub RA, et al. Among authors: rimm eb, rimm dl, d aquila t. Cancer. 1998 Apr 15;82(8):1513-20. doi: 10.1002/(sici)1097-0142(19980415)82:8<1513::aid-cncr13>3.0.co;2-7. Cancer. 1998. PMID: 9554529

3

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.

Camp RL, Rimm EB, Rimm DL. Camp RL, et al. Among authors: rimm eb, rimm dl. Cancer. 1999 Dec 1;86(11):2259-65. doi: 10.1002/(sici)1097-0142(19991201)86:11<2259::aid-cncr13>3.0.co;2-2. Cancer. 1999. PMID: 10590366

4

Quantitative examination of mechanophysical tumor cell enrichment in fine-needle aspiration specimens.

Ernst LM, Rimm DL. Ernst LM, et al. Cancer. 2002 Oct 25;96(5):275-9. doi: 10.1002/cncr.10746. Cancer. 2002. PMID: 12378594 Free article.

5

Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer.

Kang JY, Dolled-Filhart M, Ocal IT, Singh B, Lin CY, Dickson RB, Rimm DL, Camp RL. Kang JY, et al. Cancer Res. 2003 Mar 1;63(5):1101-5. Cancer Res. 2003. PMID: 12615728

6

alphaB-crystallin as a marker of lymph node involvement in breast carcinoma.

Chelouche-Lev D, Kluger HM, Berger AJ, Rimm DL, Price JE. Chelouche-Lev D, et al. Among authors: rimm dl. Cancer. 2004 Jun 15;100(12):2543-8. doi: 10.1002/cncr.20304. Cancer. 2004. PMID: 15197794 Free article.

7

Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome.

Dolled-Filhart M, McCabe A, Giltnane J, Cregger M, Camp RL, Rimm DL. Dolled-Filhart M, et al. Cancer Res. 2006 May 15;66(10):5487-94. doi: 10.1158/0008-5472.CAN-06-0100. Cancer Res. 2006. PMID: 16707478

8

Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma.

Yang XR, Charette LA, Garcia-Closas M, Lissowska J, Paal E, Sidawy M, Hewitt SM, Rimm DL, Sherman ME. Yang XR, et al. Diagn Mol Pathol. 2006 Sep;15(3):157-61. doi: 10.1097/01.pdm.0000213453.45398.e0. Diagn Mol Pathol. 2006. PMID: 16932071

9

Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis.

Sherman ME, Rimm DL, Yang XR, Chatterjee N, Brinton LA, Lissowska J, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Cartun R, Mandich D, Rymkiewicz G, Ligaj M, Lukaszek S, Kordek R, Kalaylioglu Z, Harigopal M, Charrette L, Falk RT, Richesson D, Anderson WF, Hewitt SM, García-Closas M. Sherman ME, et al. Among authors: rimm dl. Int J Cancer. 2007 Sep 1;121(5):1079-85. doi: 10.1002/ijc.22812. Int J Cancer. 2007. PMID: 17487843 Free article.

10

Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study.

Yang XR, Pfeiffer RM, Garcia-Closas M, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Cartun RW, Mandich D, Sasano H, Evans DB, Sutter TR, Sherman ME. Yang XR, et al. Among authors: rimm dl. Cancer Res. 2007 Nov 1;67(21):10608-17. doi: 10.1158/0008-5472.CAN-07-2142. Epub 2007 Oct 29. Cancer Res. 2007. PMID: 17968031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

537 results

Search Page